Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01349660
What this trial is testing

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
SCRI Development Innovations, LLC 88
Early research (Phase 1)Study completedNCT03232424
What this trial is testing

NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma, Adult
Hackensack Meridian Health 12
Very early researchNot Yet RecruitingNCT07515924
What this trial is testing

Oral Gallium Maltolate for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Medical College of Wisconsin 8
Not applicableWithdrawnNCT04926168
What this trial is testing

6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)

Who this might be right for
MGMT-Methylated Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT03158389
What this trial is testing

NCT Neuro Master Match - N²M² (NOA-20)

Who this might be right for
Glioblastoma, Adult
University Hospital Heidelberg 228
Testing effectiveness (Phase 2)Study completedNCT00099060
What this trial is testing

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02038218
What this trial is testing

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

Who this might be right for
Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
DEKK-TEC, Inc. 29
Not applicableStudy completedNCT00376818
What this trial is testing

Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers

Who this might be right for
Brain and Central Nervous System TumorsPsychosocial Effects of Cancer and Its Treatment
Case Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00045110
What this trial is testing

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more
National Cancer Institute (NCI) 136
Not applicableStudy completedNCT04143425
What this trial is testing

Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Who this might be right for
Adult GlioblastomaMagnetic Resonance ImagingBevacizimab
Ho Sung Kim 15
Early research (Phase 1)Study completedNCT00354068
What this trial is testing

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 65
Not applicableNot Yet RecruitingNCT06781372
What this trial is testing

Patient's Derived Organoids for Drug Screening in Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme (GBM)Glioblastoma Multiforme, Adult
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Early research (Phase 1)Study completedNCT01905228
What this trial is testing

Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm

Who this might be right for
Solid TumorsGlioblastoma
Incuron 83
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Ended earlyNCT01339039
What this trial is testing

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Who this might be right for
High Grade Glioma: Glioblastoma (GBM)High Grade Glioma: GliosarcomaAnaplastic Astrocytoma (AA)+2 more
Patrick Y. Wen, MD 26
Very early researchUnknownNCT05043701
What this trial is testing

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Oslo University Hospital 15
Not applicableStudy completedNCT05186064
What this trial is testing

Glioblastoma Targeted Treatment Option Maximization by WGS

Who this might be right for
Glioblastoma
UMC Utrecht 164
Testing effectiveness (Phase 2)Study completedNCT00657267
What this trial is testing

Dose-Intense Temozolomide in Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Patrick Y. Wen, MD 58
Testing effectiveness (Phase 2)Study completedNCT00004200
What this trial is testing

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Not applicableWithdrawnNCT05410301
What this trial is testing

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Varun Monga, MD
Next Page